5/29/2020 8:02:19 AM
Amgen Announces New AMG 510 Clinical Data Across Multiple Solid Tumors During ASCO20 Virtual Scientific Program
5/8/2020 8:32:40 AM
Amgen And Cytokinetics: FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure
5/6/2020 9:02:45 AM
Amgen Announces Positive Top-line Results From ADVANCE Trial
5/5/2020 9:01:17 AM
Amgen Says KYPROLIS Patents Upheld Against Generic Manufacturer
4/30/2020 4:02:08 PM
Amgen Q1 Non-GAAP EPS Increase 17% To $4.17
4/7/2020 9:17:37 PM
Amgen, Adaptive Biotechnologies To Participate In Webinar On COVID-19 Strategic Collaboration
4/2/2020 9:02:34 AM
Amgen And Adaptive Biotechnologies Announce Collaboration To Develop Therapeutic To Prevent Or Treat COVID-19
3/31/2020 8:42:35 PM
Amgen Consummates Purchase Of 49% Of Shares Of Amgen Astellas BioPharma From Astellas
3/4/2020 4:08:07 PM
Amgen Inc. (AMGN) Declares $ 1.60 Dividend for Q2 20, Record Date 5/18/2020
3/4/2020 4:06:29 PM
Amgen Declares Quarterly Dividend Of $1.60/share, Payable June 8/ Record May 18
2/26/2020 8:31:41 AM
Amgen, Cytokinetics And Servier Report Continuation Of GALACTIC-HF Following Planned Interim Analysis
1/31/2020 9:12:10 AM
William Blair Is Increasing Amgen Inc. (AMGN) 2022 Rev. Estimate To 25.80 Billion From 25.61 Billion